Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
1.970
-0.070 (-3.43%)
At close: Apr 2, 2026, 4:00 PM EDT
1.940
-0.030 (-1.52%)
After-hours: Apr 2, 2026, 6:20 PM EDT
Equillium Market Cap
Equillium has a market cap or net worth of $124.56 million as of April 2, 2026. Its market cap has increased by 334.12% in one year.
Market Cap
124.56M
Enterprise Value
95.00M
1-Year Change
334.12%
Ranking
Category
Stock Price
$1.97
Market Cap Chart
Since October 12, 2018, Equillium's market cap has decreased from $234.54M to $124.56M, a decrease of -46.89%. That is a compound annual growth rate of -8.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 124.56M | 31.97% |
| Dec 31, 2025 | 94.38M | 256.04% |
| Dec 31, 2024 | 26.51M | 4.40% |
| Dec 29, 2023 | 25.39M | -30.27% |
| Dec 30, 2022 | 36.41M | -67.14% |
| Dec 31, 2021 | 110.80M | -16.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Black Diamond Therapeutics | 136.92M |
| Kalaris Therapeutics | 134.59M |
| Karyopharm Therapeutics | 132.78M |
| Alpha Cognition | 130.24M |
| Agenus | 128.25M |
| Innate Pharma | 125.73M |
| Sangamo Therapeutics | 124.32M |
| PepGen | 119.57M |